|
Contents |
|
|
|
|
|
|
Glioblastoma
|
 
|
|
|
Baumann F, Bjeljac
M, Kollias SS, Baumert BG, Brandner S, Rousson V, Yonekawa Y, Bernays RL.
Combined thalidomide and temozolomide treatment in patients with
glioblastoma multiforme.
J Neurooncol.
2004 Mar-Apr;67(1-2):191-200.
.JPG)
Abstract
| .png)
Reprint
| .gif) Related
articles
|
|
M.
Bjeljac, F. Baumann and R. Bernays
Combined
thalidomide and temozolomide treatment in patients with glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 451
|
|
J.
N. Capparella, V. M. Johnson, X. Maestri-Moden, P. Sampath, N. Ready,
L. Alderson
Phase II trial of daily oral temozolomide
and thalidomide in newly diagnosed glioblastoma multiforme before
radiation therapy
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
483
|
|
Chang SM, Lamborn
KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK,
Prados MD.
Phase II study of temozolomide and thalidomide with radiation therapy
for newly diagnosed glioblastoma multiforme.
Int
J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):353-7.
Abstract
| Related
articles
|
|
|
Drappatz J, Wong ET, Schiff D, Kesari S,
Batchelor TT, Doherty L, Lafrankie DC, Ramakrishna N, Weiss S, Smith ST,
Ciampa A, Zimmerman J, Ostrowsky L, David K, Norden A, Barron L, Sceppa C,
Black PM, Wen PY.
A Pilot Safety Study of Lenalidomide and Radiotherapy for Patients with
Newly Diagnosed Glioblastoma Multiforme
Int
J Radiat Oncol Biol Phys. 2008 May 29. [Epub ahead of print]
Abstract
|
|
|
Fadul CE, Kingman LS, Meyer LP, Cole BF, Eskey
CJ, Rhodes CH, Roberts DW, Newton HB, Pipas JM.
A phase II study of thalidomide and irinotecan for treatment of
glioblastoma multiforme
J Neurooncol. 2008 Jul 26; [Epub ahead of print]
Abstract
|
|
|
Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor
TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM,
Drappatz J, Ciampa A, Folkman J, Kieran M, Wen PY.
Phase
II study of temozolomide, thalidomide, and celecoxib for newly
diagnosed glioblastoma in adults.
Neuro Oncol. 2008 Jun;10(3):300-8.
Epub 2008 Apr 10.
Abstract |
Reprint |
Related articles
|
|
Riva M, Imbesi F, Beghi E, Galli C, Citterio A,
Trapani P, Sterzi R, Collice M.
Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
Anticancer Res. 2007
Mar-Apr;27(2):1067-71
Abstract
|
Reprint
| Related
articles
|
|
Christopher D. Turner, Susan Chi,
Karen J. Marcus, Tobey MacDonald, Roger J. Packer, Tina Young Poussaint,
Sridhar Vajapeyam, Nicole Ullrich, Liliana C. Goumnerova, R. Michael Scott,
Caitlin Briody, Christine Chordas, Mary Ann Zimmerman and
Mark W. Kieran
Phase II study of thalidomide and radiation in children with newly diagnosed
brain stem gliomas and glioblastoma multiforme
J Neurooncol. 2006 Sep 22; [Epub
ahead of print]
Abstract
|
|
|
Recurrent
Tumors
|
|
|
|
Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in
Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract
No.
551
|
|
Groves MD, Puduvalli VK, Chang SM, Conrad CA,
Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen
PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK.
A North American brain tumor consortium (NABTC 99-04) phase II trial of
temozolomide plus thalidomide for recurrent glioblastoma multiforme
J Neurooncol. 2007
Feb;81(3):271-7. Epub 2006 Sep 22.
Abstract
|
Reprint
| Related
articles
|
|
Marx GM,
Pavlakis N, McCowatt S, Boyle FM, Levi JA, Bell DR, Cook R, Biggs M, Little N,
Wheeler HR
Phase II study of thalidomide in the treatment of
recurrent glioblastoma multiforme
J Neurooncol 2001 Aug;54(1):31-8 (Abstract+)
|
|
|
Surasak Phuphanich
Recurrent
Multicentric Glioblastoma Multiforme Responds to Thalidomide and
Chemotherapy
Oncology, Vol 16, No 3 (March 2002), Letter to the
Editor
Abstract |
.png)
Full Text |
Reprint
|
|
|
Puduvalli VK, Giglio P, Groves MD, Hess KR,
Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H,
de Groot JF, Ritterhouse MG, Ictech SE, Yung WK
Phase II trial of irinotecan and thalidomide in adults with recurrent
glioblastoma multiforme
Neuro Oncol. 2008 Feb 26; [Epub ahead of print]
Abstract
|
|
|
Gliomas
|
|
|
|
T. Ahmed, B. Chen,
G. Rabbani, M. N. Wallam and D. Benzil
Phase II trial of thalidomide (TD), tamoxifen
(TX), and temozolomide (T) for patients with advanced malignant gliomas (MG)
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1575
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement),
2005: 1575
|
|
|
A. Desjardins, J. A. Quinn, D. A.
Reardon, J. N. Rich, J. J. Vredenburgh, C. Efird, H. S. Friedman
Phase II study of thalidomide and daily
cyclophosphamide for adults with malignant glioma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1554
|
|
|
Gao
S, Yang XJ, Zhang WG, Ji YW, Pan Q
Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG
glioma cells in vitro
Chin Med J (Engl). 2009 Jun 5;122(11):1260-6
Abstract |
Full Text |
Reprint
|
|
|
M. Gelati, E. Corsini, S. Frigerio, B. Pollo, G. Broggi,
D. Croci, A. Silvani, A. Boiardi, A. Salmaggi
Effects
of Thalidomide on Parameters Involved in Angiogenesis: An in vitro
Study
Journal of Neuro-Oncology, 64 (3): 193-201, September 2003
|
|
|
Recurrent
Tumors
|
|
|
|
W.
Adler, F. C. Lee
A
phase I trial using combination irinotecan and thalidomide for recurrent CNS
tumors
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 489
|
|
|
Fine HA, Kim L, Albert PS, Duic JP, Ma H, Zhang
W, Tohnya T, Figg WD, Royce C
A phase I trial of lenalidomide in patients with recurrent primary
central nervous system tumors
Clin Cancer Res. 2007 Dec 1;13(23):7101-6
Abstract
|
|
Fine HA,
Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf
CB
Phase
II trial of thalidomide and carmustine for patients with recurrent high-grade
gliomas
J Clin Oncol. 2003 Jun 15;21(12):2299-304
|
|
H.
A. Fine, L. Kim, C. Royce, J. P. Duic, L. J. Cohen, S. Mitchell
A
phase I trial of CC-5103, a potent thalidomide analog, in patients with
recurrent high-grade gliomas and other refractory CNS malignancies
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
418
|
|
Fine
HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black
PM, Kaplan R, Pluda JM, Yung WK
Phase II trial of
the antiangiogenic agent thalidomide in patients with recurrent high-grade
gliomas
J Clin
Oncol 2000 Feb;18(4):708-15 (PDF Full Text)
|
|
HA
Fine, JS Loeffler, A Kyritsis, P Wen, PM Black, VA Levin, S Graham, WKA Yung
A phase II trial of the anti-angiogenic agent,
thalidomide, in patients with recurrent high-grade gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1372
|
|
|
Giglio
P, Dhamne M, Hess KR, Gilbert MR, Groves MD, Levin VA, Kang SL, Ictech SE,
Liu V, Colman H, Conrad CA, Loghin M, de Groot J, Yung WK, Puduvalli VK.
Phase 2 trial of irinotecan and thalidomide in adults with recurrent
anaplastic glioma.
Cancer. 2011 Nov 15;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill
A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J,
Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.
Phase
II study of metronomic chemotherapy for recurrent malignant gliomas in
adults.
Neuro Oncol. 2007
Jul;9(3):354-63.
Epub 2007 Apr 23.
Abstract |
Reprint |
Related articles
|
|
|
Ruiz J, Case D, Enevold
G, Rosdhal R, Tatter SB, Ellis TL, McQuellon RP, McMullen KP, Stieber VW,
Shaw EG, Lesser GJ.
A
phase II trial of thalidomide and procarbazine in adult patients with
recurrent or progressive malignant gliomas.
J Neurooncol. 2011 Aug 26. [Epub ahead of print]
Abstract |
Related articles
|
|
Short
SC, Traish D, Dowe A, Hines F, Gore M, Brada M
Thalidomide
as an anti-angiogenic agent in relapsed gliomas
J Neurooncol. 2001 Jan;51(1):41-5. (Abstract+)
|
|
|
Pediatric
Patients
|
|
|
|
|
López-Aguilar E, Sepúlveda-Vildósola AC,
Betanzos-Cabrera Y, Rocha-Moreno YG, Gascón-Lastiri G, Rivera-Márquez H,
Wanzke-Del-Angel V, Cerecedo-Díaz F, Cruz-Yañez Hde L.
Phase II Study of Metronomic Chemotherapy with Thalidomide,
Carboplatin-Vincristine-Fluvastatin in the Treatment of Brain Stem Tumors in
Children
Arch Med Res. 2008 Oct;39(7):655-62; Epub 2008 Aug 17
Abstract
|
|
|
Recurrent
Tumors
Warren KE, Goldman S, Pollack IF, Fangusaro J, Schaiquevich P, Stewart CF,
Wallace D, Blaney SM, Packer R, Macdonald T, Jakacki R, Boyett JM, Kun LE.
Phase
I Trial of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or
Progressive Primary CNS Tumors: Pediatric Brain Tumor Consortium Study
PBTC-018.
J
Clin Oncol. 2010 Dec 13. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Cancer
Research
|
|
|
|
Belo
AV, Barcelos LS, Teixeir MM, Ferreira MA, Andrade SP.
Differential effects
of antiangiogenic compounds in neovascularization, leukocyte recruitment,
VEGF production, and tumor growth in mice.
Cancer
Invest. 2004;22(5):723-9
|
|
|
Chaudhry
V, Cornblath DR, Corse A, Freimer M, Simmons-O'Brien E, Vogelsang G
Thalidomide-induced
neuropathy
Neurology
2002 Dec 24;59(12):1872-5
|
|
Verheul
HM, Panigrahy D, Yuan J, D'Amato RJ
Combination
oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth
in rabbits
Br J
Cancer 1999 Jan;79(1):114-8
|
|
